Recall Announced For Diabetes Test Strips Due To Errors In Results
August 26, 2013
The U.S. Food and Drug Administration (FDA) has partnered with Nova Diabetes Care in initiating the voluntary recall of roughly 62 million blood glucose testing strips due to potential errors in test results. The St. Louis Defective Medical Device Lawyers with CofmanTownsley point out these errors could lead to patients suffering serious adverse health events.
According to an article from KMOV 4 News, the strips can have incorrect results that show blood glucose levels being much higher than they actually are. These errors could cause patients to make mistakes when using medications, like insulin, to regulate blood sugar levels. These errors could potentially result in patients suffering adverse health events, including seizures and death.
The reason for the test result errors is due to contamination of the strips by a chemical used in the manufacturing process.
Those who are in possession of the affected products should halt their use immediately and then contact the company for refunds or replacements of the product. Those who have been harmed as a result of using the strips should contact the FDA’s MedWatch program so the incident can be recorded.
CofmanTownsley’s team of St. Louis Personal Injury Lawyers would also encourage anyone who has been harmed by the strips to discuss their legal options with a qualified attorney. Doing so will help victims get the compensation they are legally entitled to.